Summary
Updated Aug 30, 2026
Growth N. V. Biotech files SEC Form 4 reports at ESSA Pharma Inc. (EPIX). 1 SEC Form 4 filing on record, dated 5 November 2024. Most recent open-market trade: sold $2.84M of EPIX on 5 November 2024. Lifetime open-market sales: $12.02M.
Recent Transactions
4Every recent SEC Form 4 transaction Growth N. V. Biotech has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Growth N. V. Biotech. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Virsik - $4K of EPIX open-market activity on record
- BVF PARTNERS L P - $293 of EPIX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Growth N. V. Biotech?
Growth N. V. Biotech is a corporate insider of ESSA Pharma Inc. (EPIX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Growth N. V. Biotech last file a Form 4?
The only primary Form 4 on record is dated 5 November 2024.
Has Growth N. V. Biotech been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($12.02M) across all tracked filings.
Where can I see all of Growth N. V. Biotech's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Growth N. V. Biotech and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
